News Focus
News Focus
icon url

alertmeipp

01/01/25 12:26 PM

#3861 RE: dewophile #3859

Agreed, nothing in investing is guaranteed. However, the odds here remain compelling, with the potential upside significantly outweighing the downside. The current cash burn guidance already factors in RSV Phase 3, and a partnership seems like the more probable scenario. It’s unlikely the CEO would risk the entire company on RSV alone. A deal with substantial upfront payments could drastically improve the outlook.

I had a similar perspective when the stock was trading at twice its current price just weeks ago, so WDIK.
icon url

alertmeipp

01/01/25 12:29 PM

#3862 RE: dewophile #3859

either a deal or restructure as an immunology company with lower burn



Maybe it will be sold at a nice premium. 😀💲